◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2581

BenQ BM Holding Cayman Corp. (2581) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-10

BenQ BM Holding Cayman Corp. (2581) operates in the Medical Care Facilities industry and is headquartered in Nanjing, China with about 3,795 employees. Its market capitalization is roughly CNY 872 million. In the fiscal year ended 2025-12-31, 2581 reported CNY 2.7B in revenue and CNY 95M in net income.

BenQ BM Holding Cayman Corp., through its subsidiaries, owns and operates hospitals in the People's Republic of China. It operates two general hospitals, namely Nanjing BenQ Hospital and Suzhou BenQ Hospital.

Interactive charts & full statements →

2581 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total RevenueCNY 2.7BCNY 2.7BCNY 2.7BCNY 2.3B
Gross ProfitCNY 424MCNY 482MCNY 508MCNY 383M
Operating Income (EBIT)CNY 154MCNY 195MCNY 263MCNY 173M
Net IncomeCNY 95MCNY 109MCNY 167MCNY 90M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2581 Free Cash Flow History

2581 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total AssetsCNY 3.9BCNY 3.1BCNY 2.9BCNY 2.6B
Total LiabilitiesCNY 1.6BCNY 1.5BCNY 1.4BCNY 1.2B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2581 viewer.

Other Companies in Medical Care Facilities

← 2580All “0-9” companies2582 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.